Anthony Lombardo is reportedly leaving his position as head ofLockheed Martin Western Development Laboratories Medical ImagingSystems, according to sources close to the Hoffman Estates, IL,PACS developer. Lombardo is a former veteran of Philips'
Anthony Lombardo is reportedly leaving his position as head ofLockheed Martin Western Development Laboratories Medical ImagingSystems, according to sources close to the Hoffman Estates, IL,PACS developer. Lombardo is a former veteran of Philips' CommViewPACS project and has led the Lockheed Martin unit since its earlierincarnation, Loral Medical Imaging Systems (SCAN 9/14/94). Theunit became a part of Lockheed Martin after the defense contractorbought Loral earlier this year. Lockheed Martin representativesdeclined to comment on Lombardo's reported departure.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.